Vaxart Inc (VXRT)

Vaxart (VXRT) Stock Price & Analysis


VXRT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.56 - $4.62
Previous Close$1.26
Average Volume (3M)1.51M
Market Cap
Enterprise Value$120.56M
Total Cash (Recent Filing)$71.81M
Total Debt (Recent Filing)$21.52M
Price to Earnings (P/E)-1.5
Aug 10, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.83
Shares Outstanding135,597,316
10 Day Avg. Volume1,794,322
30 Day Avg. Volume1,507,971
Standard Deviation0.56
Financial Highlights & Ratios
Price to Book (P/B)2.19
Price to Sales (P/S)430.36
Price to Cash Flow (P/CF)-1.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue303.67
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.19
Price Target Upside352.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Vaxart Inc’s price range in the past 12 months?
Vaxart Inc lowest stock price was $0.56 and its highest was $4.62 in the past 12 months.
    What is Vaxart Inc’s market cap?
    Currently, no data Available
    When is Vaxart Inc’s upcoming earnings report date?
    Vaxart Inc’s upcoming earnings report date is Aug 10, 2023 which is in 65 days.
      How were Vaxart Inc’s earnings last quarter?
      Vaxart Inc released its earnings results on May 04, 2023. The company reported -$0.19 earnings per share for the quarter, missing the consensus estimate of -$0.187 by -$0.003.
        Is Vaxart Inc overvalued?
        According to Wall Street analysts Vaxart Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Vaxart Inc pay dividends?
          Vaxart Inc pays a Notavailable dividend of $12.19 which represents an annual dividend yield of N/A. See more information on Vaxart Inc dividends here
            What is Vaxart Inc’s EPS estimate?
            Vaxart Inc’s EPS estimate is -$0.18.
              How many shares outstanding does Vaxart Inc have?
              Vaxart Inc has 135,597,320 shares outstanding.
                What happened to Vaxart Inc’s price movement after its last earnings report?
                Vaxart Inc reported an EPS of -$0.19 in its last earnings report, missing expectations of -$0.187. Following the earnings report the stock price went up 1.163%.
                  Which hedge fund is a major shareholder of Vaxart Inc?
                  Among the largest hedge funds holding Vaxart Inc’s share is GMT Capital Corp. It holds Vaxart Inc’s shares valued at N/A.


                    Vaxart Stock Smart Score

                    The Vaxart stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Vaxart Inc

                    Biota Holdings Ltd. operates as an anti infective drug development firm. The company was founded on October 2, 1985 and is headquartered in Notting Hil, Australia.


                    Top 5 ETFs holding VXRT

                    Market Value
                    Smart Score
                    Vanguard Health Care ETF
                    iShares Core S&P Total U.S. Stock Market ETF
                    Fidelity Nasdaq Composite Index ETF
                    Schwab U.S. Broad Market ETF
                    iShares Russell 3000 ETF
                    Up to five ETFs with an Outperform Smart Score that hold VXRT. The ETFs are listed according to market value of VXRT within the ETF


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Inovio Pharmaceuticals
                    BioNTech SE

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis